IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of ...

Phase 1 dose escalation trial in SMARCA4 (BRG1)-mutated cancer remains on track with non-small cell lung cancer ...

Region X has identified 289 barangays across Bukidnon as susceptible to rain-induced landslides and flooding ahead of the ...

Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; ...

Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors ...

Have you noticed how the Canadiens have quite a few goalies in the branches? Samuel Montembeault and Jakub Dobes are upstairs ...

Konyushkov is an intriguing prospect. While the stat line isn’t the best with regard to points, he still logs around 22 minutes a night for Torpedo, the second-ranked team in the western conference ...

The company's outlook for the rest of the year was rosier than in the previous quarter, when it announced a cost-cutting plan ...

Aitcheson buries back-to-back OT winners, Veilleux scores his first NCAA goal and more in this week’s prospect report ...

With just two months of 2025 remaining, the ASX healthcare sector is in need of a stronger prescription to turn its fortunes around after another dose of weakness in October.

Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...